These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability]. Tatarchenko IP; Pozdniakova NV; Shevyrev VA; Morozova OI Kardiologiia; 2003; 43(2):65-8. PubMed ID: 12891276 [TBL] [Abstract][Full Text] [Related]
4. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
5. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. Singh BN Eur Heart J; 1993 Nov; 14 Suppl H():14-23. PubMed ID: 7904934 [TBL] [Abstract][Full Text] [Related]
6. Is there a need for new antiarrhythmic drugs? Roden DM Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic drugs: electrophysiological basis of their clinical usage. Weng JT; Smith DE; Moulder PV Ann Thorac Surg; 1986 Jan; 41(1):106-12. PubMed ID: 2417568 [TBL] [Abstract][Full Text] [Related]
11. [Ionic mechanisms of action of class III antiarrhythmic drugs]. Kuz'min VS; Rozenshtraukh LV Kardiologiia; 2010; 50(7):49-61. PubMed ID: 20659045 [TBL] [Abstract][Full Text] [Related]
12. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators. Ho AT; Pai SM; Timothy P; Pai RG Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799 [TBL] [Abstract][Full Text] [Related]
13. The role of class III antiarrhythmic agents in maintaining sinus rhythm. Brachmann J Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519 [TBL] [Abstract][Full Text] [Related]
16. Drugs with a class III antiarrhythmic action. Bexton RS; Camm AJ Pharmacol Ther; 1982; 17(3):315-55. PubMed ID: 6761715 [No Abstract] [Full Text] [Related]